EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Therapeutic potential and safety challenges of antimicrobial peptides and peptidomimetics against ESKAPEE pathogens: a systematic review with quantitative analysis

Elias Shiferaw Mekonen iD, Shyam Kumar Mishra iD, Umme Laila Urmi, Yihenew Million Yeshtila, Furqan A Maulvi, Naresh Kumar, Mark D P Willcox iD

Journal of Antimicrobial Chemotherapy · 02.07.2026 · 81 (8)

DOI: 10.1093/jac/dkag255 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 27.07.2026. Verfasst von Elias Shiferaw Mekonen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Optometry and Vision Science, Faculty of Health and Medicine, University of New South Wales, Sydney, NSW 2052, Australia. Hauptthemen laut MEDLINE: Peptidomimetics, Antimicrobial Peptides, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial peptides and peptidomimetics have emerged as promising alternatives to traditional antibiotics for MDR bacterial infections. Their advancement, however, is often limited by toxicity and poor pharmacokinetics. In this review, we apply a rigorous quantitative framework to evaluate the therapeutic balance of potency and safety for these agents, offering new perspectives that extend beyond previous descriptive analyses.

Methods

We systematically searched key biomedical databases (January 2000 to May 2025) for studies reporting antimicrobial potency, cytotoxicity, selectivity index, stability and in vivo efficacy. Bias was assessed using an adapted laboratory animal experimentation quality tool. Data were synthesized using a pooled geometric mean approach to compare therapeutic windows across compound.

Results

Of 136 peptides from 47 studies, natural antimicrobial peptides were most potent in vitro against Gram-negative bacteria but frequently caused significant host toxicity. Limited cytotoxicity data prevented robust selectivity analysis for these natural compounds. Peptidomimetics generally provided a wider safety margin than synthetic peptides, though toxicity was context dependent. Major translational barriers, including protein binding and cation effects, diminished in vivo efficacy. Notably, some rationally designed compounds achieved therapeutic benefit in animal models without acute toxicity, unlike traditional agents such as polymyxin B.

Conclusions

Advancing antimicrobial peptides and peptidomimetics into clinical use will require overcoming the fundamental trade-off between potency and safety. Natural compounds remain restricted by toxicity, while synthetic agents and peptidomimetics promise better safety but face pharmacokinetic challenges. Future research should prioritize innovative delivery approaches to enhance efficacy and reduce toxicity, enabling these novel therapies to address MDR infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidomimeticsAntimicrobial PeptidesAnti-Bacterial AgentsAnimalsHumansGram-Negative BacteriaMicrobial Sensitivity Tests

Substanzen

PeptidomimeticsAntimicrobial PeptidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Optometry and Vision Science, Faculty of Health and Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
  • Paediatrics and Child Health, School of Clinical Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
  • School of Chemistry, University of New South Wales, Sydney, NSW 2052, Australia.

ORCID-Profile: Elias Shiferaw Mekonen, Shyam Kumar Mishra, Mark D P Willcox

Zitieren

APA

Mekonen, E. S., Mishra, S. K., Urmi, U. L., Yeshtila, Y. M., Maulvi, F. A., Kumar, N., & Willcox, M. D. P. (2026). Therapeutic potential and safety challenges of antimicrobial peptides and peptidomimetics against ESKAPEE pathogens: a systematic review with quantitative analysis. Journal of Antimicrobial Chemotherapy, 81(8). https://doi.org/10.1093/jac/dkag255

Vancouver

Mekonen ES, Mishra SK, Urmi UL, Yeshtila YM, Maulvi FA, Kumar N, et al. Therapeutic potential and safety challenges of antimicrobial peptides and peptidomimetics against ESKAPEE pathogens: a systematic review with quantitative analysis. Journal of Antimicrobial Chemotherapy. 2026;81(8). doi:10.1093/jac/dkag255

BibTeX
@article{Mekonen2026,
  author = {Mekonen, Elias Shiferaw and Mishra, Shyam Kumar and Urmi, Umme Laila and Yeshtila, Yihenew Million and Maulvi, Furqan A and Kumar, Naresh and Willcox, Mark D P},
  title = {Therapeutic potential and safety challenges of antimicrobial peptides and peptidomimetics against ESKAPEE pathogens: a systematic review with quantitative analysis},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {8},
  doi = {10.1093/jac/dkag255}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche